The Market and Potential for CRISPR/Cas9 Gene Editing
This report consolidates the information and trends and provides reliable market estimates for CRISPR technology to 2023. As part of the report's coverage, it provides the following:
Market Size and Forecast for CRISPR/Cas9 Gene Editing, 2017-2023
The Market for CRISPR/Cas9 by Region (N. Amer. EU, ROW), 2017-2023 Analysis of Growth Trend by Region
Market by Application (Cancer Research, Non-Cancer Disease Research, Cancer Diagnostics, Infection Diagnostics, Plant, Food, Biofuel, Drug Discovery, Drug Development, Other)
Growth Trend, U.S.
Growth Trend, Outside U.S.
Market by End User (Hospitals, University, Medical Research Institute, Government), 2017
Market by End User (Hospitals, University, Medical Research Institute, Government), 2023
Recent Technology and Market Developments and Medical Studies
Partnerships Involving CRISPR Gene Editing
Companies in the Market and Partnerships in Gene Editing
In 2018, more than 30 players participate in this market, from large multinational corporations to small, niche life sciences companies. Key players include Agilent, MilliporeSigma, GE Healthcare Dharmcon, GeneScript, Horizon Discovery Group, OriGene, ThermoFisher Scientific, Transposagen, and ToolGen. These companies develop and commercialize various products and services for each of the major gene editing technologies.
The nature of CRISPR’s complex technology requires partnerships between the developers of the technology and the healthcare concerns with distribution strength and a broader product base. These developments are outlined in the report.
Recent Lawsuit and Industry Risk Analysis
Currently, one of the more significant factors in commercializing CRISPR-Cas9 as a viable therapeutic tool is the current legal battles surrounding the technology. The issue started when both the University of California, Berkeley (UCB) and the Broad Institute of MIT (the Broad) both filed patents related to this technology. While there's been some resolution, the report provides an analysis of developments.
Search inside this report
Single User License
Departmental Site License (one location, 10 users)